NCT06479460View on ClinicalTrials.gov

Clinical Application of ctDNA Dynamic Monitoring in Neoadjuvant Therapy for HER2-positive Breast Cancer Patients

RecruitingOBSERVATIONAL
Enrollment

50

Participants

Timeline

Start Date

March 8, 2024

Primary Completion Date

May 31, 2025

Study Completion Date

March 31, 2026

Conditions
Breast CancerNeoadjuvantHER2-positive Breast CancerCirculating Tumor DNA
Interventions
DIAGNOSTIC_TEST

ctDNA-MRD

This study is an observational non intervention study that only tests peripheral blood samples from different treatment nodes of the subjects, without interfering with the normal clinical diagnosis and treatment process of the patients.

Trial Locations (1)

210029

RECRUITING

Jiangsu Province Hospital, Nanjing

All Listed Sponsors
lead

The First Affiliated Hospital with Nanjing Medical University

OTHER